绿竹生物-B2024年中期报告

股份代號: 2480（於中華人民共和國註冊成立的股份有限公司） 中 期 報 告2024 24561524252627282943 •8835 3212101-2105 183401 (FCG HKFCG(PE)) (FCG HKFCG(PE)) 112-14 7 3 H 1617 13 2480 www.luzhubiotech.com 3 202358 3485 20232024630 2001 2024630LZ901 2024630LZ901 H202358H241.6 Fabite®Fabite®TFabite®2-8˚C Fabite® LZ901 LZ901VZVVZVFcAPCLZ901VZVLZ901I 20239LZ901III2024126,00040202311LZ901Shingrix30050LZ901Shingrix20246LZ901III20251LZ901BLA2025 20227FDALZ901IND2023220237LZ901I2024LZ901I2024LZ901I K3 K3TNF-αHumira®20189IK3201912I2025K3III K193 K193BBCD19CD193CD3K193CD19/CD3K193Fabite®K193K193BK193201912K193I2025I 2024630RSVK333K1932 (2)K3II 202463038 GMP202463032GMP •LZ901K3K193•RSVK333K1932•• 20242023630 20236305.382.3%20246309.7 20236300.332.5%20246300.2 202363016.862.8%20246306.3(i)(ii) 202363041.29.0%202463045.0 202363033.2142.4%202463080.42024630LZ901III 202363020246300.40.4 202363026.52024630H20235 202363079.438.5%2024630109.9 2024630 25%20232024630 2023630265.077.32024630187.7 2024630200.014A.903.50%202463016.6 2024630202337.0 2024630 20242521,185200.02024630 2024630 202463014.3%2023123112.5% 2024630 2023123149.8202463025.62024630 2024630 2024630 2024630 20246302023630 H202358241.62023552023528 2024630 (1)2024630(2)20242026 2025K3IIIK32024K32026 2026 20246301482024630 2024630XVXV78352 (i) H (2)(3)2024630(4)2024630(i)34.00%46.00%(ii)60.00%80.00%(i)(ii)(iii)(iv)(5)202463049.51%(6)40.67%(i)(ii)(7)2024630202,449,032 (ii) 2024630 2024630XVXV78352C3 2024630XV23336 H (2)202463040.67%(i)(ii) (3)2024630(i)34.00%46.00%(ii)60.00%80.00%(i)(ii)(iii)(iv) (4)2024630(i)(ii)(iii)60193957.11% (5)2024630(i)(ii)40.00%40.00%20.00%20246307,776,0502,224,694(i)(ii) (6)2024630202,449,032 2024630XV23336 20211215B.3. C1 C.2.1C.2.1(i)(ii) 2024630 C3 2024630 2024630 2024630 20246301,436,000H0.71%HH 3.10(2)3.21 202463020246302410 202463013.51B(1) 202463018 2024630 24422024630343434 24102410 34 •2024821 20246 30 20246 30 20246 30 20246 30 20246 30 1. 2024630 2. 34 3. 202463020231231 202411 161177 4. 202463020236302024630 5. 20246 30 6. 7. 8. 2024630647,602,00020231231491,491,000202463018,663,0002023123119,538,0002024630628,939,00020231231471,953,000 20246 30 9. 10. 2023630 11. 12. 46,995,000202363077,277,0001,896,000202363042,846,000 20246 30 15. 20241200,000,000202442024516,564,00020274202913.50% 202333010,000,000202393,000,000202437,000,000 20246 30 16. (i)(ii) 17. 20235832.8010,386,000110,386,000289,797,000340,660,800300,183,00010,386,00041,255,000 18. (a)2022 20211 20224 202248,110,13212022(i)7,450,0007,450,00012.545.097.19(ii)1,942,320660,13212.948,110,1323,875,00020224,235,132 20225 20246 30 18. (a)2022 2022 2022C102,717,00020222022 (b) 2022618350,00010,000,000118,9523,398,68011.00 20221231 18. (b) C70,556,000 20246 30 19. 9 20. a. b. 152024630 21. FDA GMP IND K3 H202358 202358H 2015121(i)60.00%(ii)10.00%10.00%20.00%